Clinical Trials Sponsored by Synektik S.A.

Total 3164 results

PPM Services S.A.

Terminated

Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UC (SEGMENT)

Ulcerative Colitis

United States, Hungary, Slovakia, Italy, Ukraine, Bulgaria, Poland, Latvia, Canada, France
Eurofarma Laboratorios S.A.

Completed

Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2) (EVOLUTION)

Diabetes Mellitus, Type 2

Brazil
Glenmark Specialty S.A.

Completed

Efficacy and Safety of GSP 301 Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (SAR) (GSP 301-304)

Seasonal Allergic Rhinitis (SAR)

United States
Eurofarma Laboratorios S.A.

Withdrawn

Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol

Metrorrhagia

Brazil
Ferrer Internacional S.A.

Unknown

Pharmacodynamic Equivalence of Ramipril 10 mg and Atorvastatin 40 mg Administered as a Cardiovascular (CV) Polypill Acetylsalicylic Acid-Atorvastatin-Ramipril (AAR) as Compared to Monotherapy

Hypertension

United States
ASIT Biotech S.A.

Completed

Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

House Dust Mite Allergy

Germany
Janssen-Cilag, S.A.

Terminated

Registry for Analysis of Compliance in Colombian Participants With Rheumatoid Arthritis Exposed to Golimumab (Go-Compl-Ar)

Rheumatoid Arthritis

Colombia
Eurofarma Laboratorios S.A.

Completed

Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations

Healthy | Neutropenia

Brazil
Steba Biotech S.A.

Completed

Study of WST11 in Patients With Localized Prostate Cancer

Prostate Cancer

France, United Kingdom, Canada
Steba Biotech S.A.

Completed

Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer (PCM304)

Prostate Cancer

Mexico, Panama, Peru
Eurofarma Laboratorios S.A.

Withdrawn

Non-Inferiority Trial Comparing Eurofarma's Experimental Product Saccharomyces Boulardii Versus Floratil® in the Prevention of Antibiotic-Associated Diarrhea (ACROSS)

Antibiotics

Brazil
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Gastroesophageal Reflux Disease

Brazil
Eurofarma Laboratorios S.A.

Terminated

Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation (VECOR)

Unstable Angina | Non ST Segment Elevation Myocardial Infarction

Brazil
Stendhal Americas, S.A.

Completed

Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential Hypertension (FIRME-1)

Hypertension, Essential

Mexico
Steba Biotech S.A.

Terminated

Study Using WST11 in Patients With Obstructing Endobronchial Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

France
Ferrer Internacional S.A.

Completed

Hypertension Study: Multinational Torasemide Trial in Mild to Moderate Hypertension.

Hypertension
Eurofarma Laboratorios S.A.

Withdrawn

Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

Adenocarcinoma | Carcinoma | Uterine Cervix Adenosquamous Carcinoma

Brazil
BioTech Tools S.A.

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Hay Fever

Germany
BioTech Tools S.A.

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Hay Fever

Belgium
Janssen-Cilag, S.A.

Completed

Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With Schizophrenia (PRE-COG)

Schizophrenia
EDAP TMS S.A.

Unknown

Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer

Prostate Cancer

United States, Canada
Eurofarma Laboratorios S.A.

Completed

A Study of Chemoradiation Associated With Nimotuzumab as the Treatment of Locally Advanced Esophageal Cancer (NICE)

Adenocarcinoma | Esophageal Cancer

Brazil
Janssen-Cilag, S.A.

Completed

A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis

Vaginitis | Infectious Vaginosis

Mexico
Janssen-Cilag, S.A.

Completed

A Study to Evaluate Sleep Quality in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease
Eurofarma Laboratorios S.A.

Terminated

A Non-inferiority Study Comparing Two Heparin Sodium Preparations in Hip Fracture Surgery (HEP-SC)

Hip Fracture Surgery

Brazil
Faes Farma, S.A.

Completed

Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)

Chronic Urticaria | Allergic Rhinoconjunctivitis

Australia, Germany, Sweden
Faes Farma, S.A.

Completed

Oral Bioavailability of Bilastine (BIOBI)

Healthy

Spain
Faes Farma, S.A.

Completed

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Perennial Allergic Rhinitis
Ferrer Internacional S.A.

Terminated

A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Low Density Lipoprotein (LDL) Cholesterol

Elevated LDL Cholesterol

United States
Addex Pharma S.A.

Completed

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Parkinson's Disease

United States, Austria, France, Germany
Addex Pharma S.A.

Completed

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

United States, France, Germany, Netherlands, Switzerland
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority, Multicenter and Randomized, Single-Dose Study About a Treatment to Hypolactasia (LAILAI) (EF099)

Hypolactasia

Brazil
Faes Farma, S.A.

Completed

A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine

Seasonal Allergic Rhinitis
Faes Farma, S.A.

Completed

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber

Seasonal Allergic Rhinitis

Austria
Janssen-Cilag, S.A.

Completed

A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).

Pain
Janssen-Cilag, S.A.

Terminated

Safety of Rabeprazole in Patients Under Multiple Treatments

Gastroesophageal Reflux | Gastric Ulcer
Janssen-Cilag, S.A.

Terminated

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorders
Grünenthal Colombiana S.A.

Completed

Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma

Asthma

Colombia
BioTech Tools S.A.

Completed

Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
Ferrer Internacional S.A.

Completed

Study to Assess the Efficacy and Safety of GF-001001-00 Cream in Secondarily-Infected Traumatic Lesions

Secondarily Infected Traumatic Lesions

Germany
Laboratorios Goulart S.A.

Unknown

Open and Comparative Study to Measure Tolerability and Efficacy of Taro Elixir (E01GOU-INH0109)

Boils | Acne Vulgaris II or III Degree

Brazil
Laboratoires Expanscience S.A.

Completed

Evaluation of the Structure Modifying Effect of Avocado-Soybean Unsaponifiables in Hip Osteoarthritis (ERADIAS)

Hip Osteoarthritis

France
Addex Pharma S.A.

Completed

ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)

Gastroesophageal Reflux

Austria, Belgium, France, Germany
Industrial Farmacéutica Cantabria, S.A.

Not yet recruiting

A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome.

Metabolic Syndrome
Human Biome Institute S.A.

Recruiting

Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol (STOP-ARB2)

Antimicrobial Drug Resistance | Drug Resistance, Bacterial

Poland
Bial - Portela C S.A.

Recruiting

OpiCapone Effect on Motor Fluctuations and pAiN (OCEAN)

Parkinson Disease

United Kingdom
Roxall Medicina España S.A

Recruiting

Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom (HIPNOS)

Allergy to Himenoptera Venom

Spain
Nyxoah S.A.
Nyxoah Inc.

Active, not recruiting

Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM) (DREAM)

Obstructive Sleep Apnea

United States, Australia, Belgium, Germany
Philip Morris Products S.A.

Completed

Nicotine Pharmacokinetics Following Use of the P4M3 Gen 2.0 E-Cigarette Compared to Smoking Cigarettes

Nicotine | Nicotine Vaping | Vaping

United States
Azidus Brasil
Farmoquimica S.A.

Completed

Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms (Probiatop)

Signs and Symptoms, Digestive

Brazil

3

Subscribe